Abstract:
Provided herein are processes for synthesizing intermediates useful in preparing Mcl-1 inhibitors. In particular, provided herein are processes for synthesizing compound F, or a salt thereof, wherein R1 and OPG2 are described herein. Compound F can be useful in synthesizing compound A1, or a salt of solvate thereof, and compound A2, or a salt of solvate thereof.
Abstract:
The present invention relates indane compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 activators. In particular, the invention relates to compounds of Formula (I) or Formula (II), and pharmaceutically acceptable salts thereof.
Abstract:
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.
Abstract:
The present disclosure is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein ring A, G, L, R 1 , R x , R y , X 1 , X 2 , X 3 , X 4 , n, p, q and t are as defined herein, which are active as modulators of retinoid-related orphan receptor gamma t (ROR y t). These compounds prevent, inhibit, or suppress the action of ROR y t and are therefore useful in the treatment of ROR y t mediated diseases, disorders, syndromes or conditions such as, e.g., pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, psoriasis, neurodegenerative diseases and cancer (I).
Abstract translation:本发明涉及式(I)化合物及其药学上可接受的盐,其中环A,G,L,R 1,R X, R 1,X 1,X 2,X 3,X 4,X 4,X 4,X 4, n,p,q和t如本文所定义,其作为类维生素A相关孤儿受体γt(ROR y t)的调节剂是有效的。 这些化合物预防,抑制或抑制RORγτ的作用,因此可用于治疗RORγ介导的疾病,病症,综合征或病症,例如, 例如疼痛,炎症,COPD,哮喘,类风湿性关节炎,结肠炎,多发性硬化症,牛皮癣,神经退行性疾病和癌症(I)。 p>
Abstract:
Disclosed are novel compounds and methods useful in applications relating to industrial water systems. The compounds of the present invention are nitrogen-containing heterocyclic compounds comprising a benzotriazole covalently bonded to a benzimidazole moiety, and provide enhanced protection against corrosion of metals in aqueous systems. The compounds of the present invention are generally resistant to halogen attack and provide good corrosion resistance in the presence of oxidizing halogen-based biocides.
Abstract:
The present invention provides compounds of the formula wherein R 1 is selected from the group consisting of H and CH 3 ; R 2 is selected from the group consisting of H and CH 3 ; R 3 is selected from the group consisting of H, C 1 -C 3 alkyl, O(CH 2 ) 3 SO 2 CH 3 , O(CH 2 ) 2 OCH 3 , O(CH 2 ) 2 C(CH 3 ) 2 OH, CN, and OCF 2 ; or a pharmaceutical salt thereof, methods of treating diabetes, intermediates, and a process for preparing compounds of the invention.
Abstract translation:本发明提供下式化合物其中R 1选自H和CH 3; R2选自H和CH3; R 3选自H,C 1 -C 3烷基,O(CH 2)3 SO 2 CH 3,O(CH 2)2 OCH 3,O(CH 2)2 C(CH 3)2 OH,CN和OCF 2; 或其药学盐,治疗糖尿病的方法,中间体和制备本发明化合物的方法。